HFrEF Treatment - Pharmacy Freak

Mechanism of Action of Vericiguat (Verquvo)

April 10, 2026July 2, 2025 Pharmacy Freak Editorial Team Harsh Singh Rajput

Introduction Vericiguat is a soluble guanylate cyclase (sGC) stimulator used in patients with chronic heart failure with reduced ejection fraction (HFrEF) following hospitalization or intravenous diuretics. It enhances the nitric oxide (NO)–sGC–cGMP pathway to support cardiovascular function. Step-by-Step Mechanism of Action Pharmacokinetic Parameters Clinical Uses Adverse Effects Comparative Analysis Feature Vericiguat (sGC Stimulator) Nitrates PDE5 … Read more

Mechanism of Action of Entresto (Sacubitril/Valsartan)

July 1, 2025 Pharmacy Freak Editorial Team Harsh Singh Rajput

Introduction Entresto is a combination drug containing sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker (ARB). It’s primarily used for the treatment of heart failure with reduced ejection fraction (HFrEF). The combination enhances natriuretic peptide levels while blocking deleterious effects of angiotensin II, working synergistically to reduce mortality and hospitalizations in heart … Read more